Sponsor or institution
Clinical trials and research at Grupo Espanol de Tumores Neuroendocrinos
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Grupo Espanol de Tumores Neuroendocrinos that are recruiting, at sites in 4 countries (most in Spain (4), France (2), Belgium (1)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Comparing two dosing schedules of Lutetium‑177 Dotatate for slowly progressive midgut neuroendocrine tumors | Phase 3 | Caen, Caen and 20 other locations | Recruiting | Mar 17, 2025 |
| Treatment for advanced thyroid cancers using sacituzumab govitEcan | Phase 2 | Barcelona and 10 other locations | Recruiting | Jan 31, 2024 |
| Comparing radiotherapy and everolimus for treating neuroendocrine tumors in the lung and thymus | Phase 3 | Edegem, Edegem and 26 other locations | Recruiting | Jun 26, 2023 |
| Registration of patients with thyroid cancer | — | Barcelona, Barcelona | Recruiting | Dec 5, 2018 |
All recruiting trials (4)
-
Comparing two dosing schedules of Lutetium‑177 Dotatate for slowly progressive midgut neuroendocrine tumors
This will test whether giving Lu‑177 Dotatate every 16 weeks instead of every 8 weeks works as well but causes fewer blood-related side effects for people with slowly progressive, Grade 1–2 midgut neuroendocrine tumors that are somatostatin receptor–positive.
-
Treatment for advanced thyroid cancers using sacituzumab govitEcan
This study is testing a new drug called sacituzumab govitEcan to see if it can help people with advanced thyroid cancers that don't respond to traditional treatments.
-
Comparing radiotherapy and everolimus for treating neuroendocrine tumors in the lung and thymus
This study is testing whether a new treatment called 177Lu-edotreotide is better than everolimus for helping people with neuroendocrine tumors in the lung and thymus live longer without their cancer getting worse.
-
Registration of patients with thyroid cancer
This study is collecting information on adults with different types of thyroid cancer to better understand their experiences and outcomes.
Quick answers
How many clinical trials run by Grupo Espanol de Tumores Neuroendocrinos are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Spain (4 trials), France (2 trials), Belgium (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.